ACET

Adicet Bio Stock Price

12.05
0.05 (0.42%)
Upgrade to Real-Time
Afterhours (Closed)
12.05
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Adicet Bio Inc ACET NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 0.42% 12.05 20:00:00
Open Price Low Price High Price Close Price Previous Close
11.85 11.4701 12.10 12.05 12.00
Bid Price Ask Price Spread News
8.88 13.25 4.37 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
612 26,805 $ 11.93 $ 319,768 41,467 9.71 - 21.40
Last Trade Time Type Quantity Stock Price Currency
16:02:14 30 $ 12.05 USD

Adicet Bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 236.06M 19.59M 27.84M $ 12.49M $ - -2.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Adicet Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACET Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.4912.60811.470112.2133,593-0.44-3.52%
1 Month11.7513.5011.0212.2540,1100.302.55%
3 Months14.9821.409.7112.25119,149-2.93-19.56%
6 Months14.9821.409.7112.25119,149-2.93-19.56%
1 Year14.9821.409.7112.25119,149-2.93-19.56%
3 Years10.9821.400.13062.03936,8091.079.74%
5 Years28.3328.550.13065.95546,767-16.28-57.47%

Adicet Bio Description

Adicet Bio Inc is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.


Your Recent History
NASDAQ
ACET
Adicet Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.